Loading company…
Vybion, founded in 1993 in Ithaca, US, is a biotechnology firm developing Intrabody therapies for neurodegenerative diseases.
Its main product, INT41, is an AAV-delivered intrabody that targets Huntington's disease. Lee Henderson is Founder and CEO. The company's one notable deal was in 1998, when Cayuga Venture Fund provided financing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in